Heat thErapy And mobiLity in COVID-19 Survivors

Part of paid clinical trials in Omaha, Nebraska.

Sponsor
University of Nebraska
Study ID
NCT06928116
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Heat therapy — BEHAVIORAL
    At home lower body heat therapy
  • Sham Control — BEHAVIORAL
    Sham Thermoneutral
  • Walking — BEHAVIORAL
    Walking intervention

Study Details

Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".

Key Dates

Start date
Sep 17, 2025
Status verified
Jul 2025
Primary completion
Aug 31, 2028
Completion
Aug 31, 2029

Study Design

Enrollment
99 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Heat Therapy
    At home heat therapy 5 times (40-55 min) per week for 8 weeks.
  • Sham Comparator: Control Therapy
    Sham at home thermoneutral therapy 5 times (40-55 min) per week for 8 weeks.
  • Active Comparator: Walking Intervention Using Wearable Technology
    +1,500-3000 steps per day 3-5 days a week for 8 weeks.

Primary Outcome Measure

6 min walking distance [ Time Frame: 8 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Nebraska OmahaOmahaNebraska68182
Gwenael Layec, PhD
402-554-3779

Find similar trials in Omaha, NE

By specialty

Related Studies